You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA2 gene Mutation

Showing 1 - 25 of 9,351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

Recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Informational Intervention
  • Survey Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Mar 28, 2023

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

Active, not recruiting
  • Deleterious BRCA1 Gene Mutation
  • +5 more
  • Behavioral, Psychological or Informational Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Prospective Research of Outcomes After Salpingo-oophorectomy

Active, not recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

    Recruiting
    • BRCA1 Gene Mutation
    • +5 more
    • Risk-reducing salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Tilburg, Brabant, Netherlands
    • +13 more
    Nov 1, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +2 more
    • Salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Maastricht, Limburg, Netherlands
    • +12 more
    May 17, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

    Recruiting
    • BRCA1 Gene Mutation
    • +19 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • New Brunswick, New Jersey
    • +1 more
    Nov 16, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

    Recruiting
    • Advanced Breast Carcinoma
    • +14 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 31, 2022

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023